The Asia Pacific vaccine market is witnessing dynamic growth, fueled by rising awareness about immunization, government-led vaccination initiatives, and rapid advancements in vaccine technology. Valued at USD 4.56 billion in 2024, the market is expected to expand at a CAGR of 7.80% from 2025 to 2034, reaching approximately USD 9.66 billion by 2034. The increasing prevalence of infectious...